| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/05/2009 | US20090035273 Combination treatment method with interferon-tau |
| 02/05/2009 | US20090035270 COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNF alpha |
| 02/05/2009 | US20090035269 Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer |
| 02/05/2009 | US20090035258 Methods of treating cancer by administering human il-18 combinations |
| 02/05/2009 | US20090035255 Conjugate for targeting of drug |
| 02/05/2009 | US20090035254 IL-21 Variants |
| 02/05/2009 | US20090035252 Method of inducing a CTL response |
| 02/05/2009 | US20090035218 Systems and methods for tissue imaging |
| 02/05/2009 | US20090035215 Radiofluorination |
| 02/05/2009 | CA2817054A1 Composition of tumour-associated peptides and related anti-cancer vaccine |
| 02/05/2009 | CA2700004A1 Novel immunotherapy strategy |
| 02/05/2009 | CA2695384A1 Bi-dentate compounds as kinase inhibitors |
| 02/05/2009 | CA2695382A1 A fold-back diabody diphtheria toxin immunotoxin and methods of use |
| 02/05/2009 | CA2695304A1 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions |
| 02/05/2009 | CA2695297A1 Substituted cc-1065 analogs and their conjugates |
| 02/05/2009 | CA2695199A1 Human antibodies to human cd20 and method of using thereof |
| 02/05/2009 | CA2695114A1 Pyrazole compounds and their use as raf inhibitors |
| 02/05/2009 | CA2694808A1 Novel immunotherapy against neuronal and brain tumors |
| 02/05/2009 | CA2694771A1 Composition of tumour-associated peptides and related anti-cancer vaccine |
| 02/05/2009 | CA2694724A1 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 02/05/2009 | CA2694504A1 (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof |
| 02/05/2009 | CA2694391A1 Oxidized avidin with high residency time in the treated tissues |
| 02/05/2009 | CA2694389A1 Treatment of pediatric tumors |
| 02/05/2009 | CA2694218A1 Anti-mitotic agent and aurora kinase inhibitor combination as anti-cancer treatment |
| 02/05/2009 | CA2694136A1 Pi3 kinase modulators and methods of use |
| 02/05/2009 | CA2694055A1 Novel antibodies |
| 02/05/2009 | CA2693715A1 Pyrrolopyrimidines |
| 02/05/2009 | CA2693551A1 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use |
| 02/05/2009 | CA2693390A1 Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same |
| 02/05/2009 | CA2693208A1 Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis |
| 02/05/2009 | CA2691866A1 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 02/05/2009 | CA2677049A1 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 02/05/2009 | CA2663034A1 Oncolytic rhabdovirus |
| 02/04/2009 | EP2020410A1 Pyrido[2,3d]pyrimidine derivatives, process for their preparation and their therapeutical use |
| 02/04/2009 | EP2020409A1 New piperidinyl derivatives as modulators of chemokine receptor activity |
| 02/04/2009 | EP2020408A1 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 02/04/2009 | EP2020405A1 Substituted aryl or heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| 02/04/2009 | EP2020242A2 Improved Topical Medicaments and Methods for Photodynamic Treatment of Disease |
| 02/04/2009 | EP2020239A1 Use of IL-174 agonists for treating infectious diseases |
| 02/04/2009 | EP2020237A2 Ceramide and chemotherapeutic agents for inducing cell death |
| 02/04/2009 | EP2019826A1 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 02/04/2009 | EP2019675A1 Methods for treating or preventing neoplasias |
| 02/04/2009 | EP2019592A1 5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin and its preparation and use for the treatment of cancer |
| 02/04/2009 | EP1948213B1 Methods to predict and prevent resistance to taxoid compounds |
| 02/04/2009 | EP1492773B1 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| 02/04/2009 | EP1299529B1 Conserved diaphanous-related formin autoregulatory domain (dad) |
| 02/04/2009 | EP0881906B2 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 02/04/2009 | CN101360826A Anti-alpha2 integrin antibodies and their uses |
| 02/04/2009 | CN101360821A Stabilizing formulations for recombinant viruses |
| 02/04/2009 | CN101360761A Human monoclonal antibodies to protein tyrosine kinase 7 ( ptk7 ) and their use |
| 02/04/2009 | CN101360760A Biological materials and uses thereof |
| 02/04/2009 | CN101360751A Oxygen linked pyrimidine derivatives |
| 02/04/2009 | CN101360748A Inhibitors of c-met and uses thereof |
| 02/04/2009 | CN101360746A Pyrido-,pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors |
| 02/04/2009 | CN101360740A Aminopyrimidines useful as kinase inhibitors |
| 02/04/2009 | CN101360736A L-alanine derivatives |
| 02/04/2009 | CN101360728A Iap bir domain binding compounds |
| 02/04/2009 | CN101360718A Novel hydrogen sulfate salt |
| 02/04/2009 | CN101360709A Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (PBR) |
| 02/04/2009 | CN101360499A Use of pyrazolo [1 , 5 -a] pyrimidine derivatives for inhibiting protein kinases methods for inhibiting protein kinases |
| 02/04/2009 | CN101360496A Neuroendocrine tumor treatment using mTOR inhibitors |
| 02/04/2009 | CN101360495A Administration of mntor inhibitor to treat patients with cancer |
| 02/04/2009 | CN101358383A Alkanna tinctoria drug loading nano fiber, preparation and application thereof |
| 02/04/2009 | CN101358200A RNA interference expression plasmid- cationic liposome-heparin antineoplastic complexes targeting human FAK and PLK1 gene |
| 02/04/2009 | CN101357951A Method for extracting ganoderma lucidum fruitbody polysaccharide using ultrahigh pressure |
| 02/04/2009 | CN101357939A Protein conjugate and pharmaceutical compositions thereof |
| 02/04/2009 | CN101357934A Method for preparing high purity betulinic acid |
| 02/04/2009 | CN101357230A Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 02/04/2009 | CN101357226A Replication-deficient human type 3 adenovirus vaccine |
| 02/04/2009 | CN101357214A Compound cantharis drop pill and preparation method thereof |
| 02/04/2009 | CN101357213A Compound cantharis liquid formulation and preparation method thereof |
| 02/04/2009 | CN101357212A Compound cantharis injection and preparation method thereof |
| 02/04/2009 | CN101357207A Fushengkang preparation, preparation method and quality control method thereof |
| 02/04/2009 | CN101357206A Medicine for treating liver cancer and preparation method thereof |
| 02/04/2009 | CN101357205A Toxin elimination and clot absorbing traditional Chinese medicine and preparation method thereof |
| 02/04/2009 | CN101357203A Preparation for treating cancer and carcinoma and preparation method thereof |
| 02/04/2009 | CN101357202A Chinese traditional medicine for treating hepatosis and preparation method thereof |
| 02/04/2009 | CN101357152A Epiphyllum oxypetalum medicinal preparation |
| 02/04/2009 | CN101357135A Anti-cancer medicine composition containing anti-metabolism medicine |
| 02/04/2009 | CN101357134A Potenciador del efecto antitumoral y agente antitumoral |
| 02/04/2009 | CN101357128A Medicine composition for treating breast cancer |
| 02/04/2009 | CN101357126A Stable taxone albumin lipid drug-loading system and preparation method thereof |
| 02/04/2009 | CN101357029A Peony massaging pillow and production method thereof |
| 02/04/2009 | CN100457916C Solid fermenting method for vitacoenzyme medicine |
| 02/04/2009 | CN100457895C Mouse anti-human macrophage migration inhibiting factor monoclonal antibody and its application |
| 02/04/2009 | CN100457781C Antibodies against cancer |
| 02/04/2009 | CN100457766C non-natural activity dextran tetra saccharide alkyl glycoside composition and its preparation process and application |
| 02/04/2009 | CN100457758C Thienopyrrolizine derivative, its preparing method and pharmaceutical composition containing the same |
| 02/04/2009 | CN100457753C N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/04/2009 | CN100457719C Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 02/04/2009 | CN100457192C Biotin-derivatives and their conjugates with chelating agents |
| 02/04/2009 | CN100457191C Magnetic nano radioactive medicine and its preparing method |
| 02/04/2009 | CN100457190C Promoters exhibiting endothelial cell specificity and methods of using same |
| 02/04/2009 | CN100457189C Fusions of cytokines and tumor targeting proteins |
| 02/04/2009 | CN100457183C Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination |
| 02/04/2009 | CN100457181C Combination methods of inhibiting tumor growth with vascular endothelial growth factor receptor antagonist |
| 02/04/2009 | CN100457164C Preparation process of anti-tumor active constituent of compound Chinese medicine 'Yi Yi Fu Zi Bai Jiang San' |
| 02/04/2009 | CN100457119C Freeze dried ginseng polysaccharide powder for injection and its preparing process |
| 02/04/2009 | CN100457118C 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections |
| 02/04/2009 | CN100457116C Cercopithecoidealin with anti-tumor function, its preparation and use |